Fig. 7. Higher expression of miR-3148 is unfavorable prognostic factor in multiple cancer types.
Kaplan–Meier overall survival analysis for miR-3148 expression in breast, cervical, esophageal, head and neck, ovarian, pancreatic, uterine cancer and sarcoma patients. Analyses were conducted using Kaplan–Meier plotter available at http://kmplot.com/analysis/index.php?p=background. Survival curve comparison was performed using the log-rank test.